Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.

Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, Selby P, Stine SM, Fischer G.

Addiction. 2012 Nov;107 Suppl 1:5-27. doi: 10.1111/j.1360-0443.2012.04035.x. Review.

PMID:
23106923
[PubMed - indexed for MEDLINE]
2.

Methadone and buprenorphine for the management of opioid dependence in pregnancy.

Jones HE, Finnegan LP, Kaltenbach K.

Drugs. 2012 Apr 16;72(6):747-57. doi: 10.2165/11632820-000000000-00000. Review.

PMID:
22512363
[PubMed - indexed for MEDLINE]
3.

Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.

Debelak K, Morrone WR, O'Grady KE, Jones HE.

Am J Addict. 2013 May-Jun;22(3):252-4. doi: 10.1111/j.1521-0391.2012.12005.x.

PMID:
23617867
[PubMed - indexed for MEDLINE]
4.

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.

Kakko J, Heilig M, Sarman I.

Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.

PMID:
18355989
[PubMed - indexed for MEDLINE]
5.

Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.

Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G.

Addiction. 2011 Jul;106(7):1355-62. doi: 10.1111/j.1360-0443.2011.03440.x. Epub 2011 May 12.

PMID:
21438938
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Maintenance agonist treatments for opiate-dependent pregnant women.

Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M.

Cochrane Database Syst Rev. 2013 Dec 23;12:CD006318. doi: 10.1002/14651858.CD006318.pub3. Review.

PMID:
24366859
[PubMed - indexed for MEDLINE]
7.

Neonatal abstinence syndrome after methadone or buprenorphine exposure.

Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O'Grady KE, Selby P, Martin PR, Fischer G.

N Engl J Med. 2010 Dec 9;363(24):2320-31. doi: 10.1056/NEJMoa1005359.

PMID:
21142534
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Pritham UA, Paul JA, Hayes MJ.

J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):180-90. doi: 10.1111/j.1552-6909.2011.01330.x. Epub 2012 Feb 29.

PMID:
22375882
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Neonatal neurobehavior effects following buprenorphine versus methadone exposure.

Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, Fischer G.

Addiction. 2012 Nov;107 Suppl 1:63-73. doi: 10.1111/j.1360-0443.2012.04040.x.

PMID:
23106928
[PubMed - indexed for MEDLINE]
10.

Breastfeeding promotion for management of neonatal abstinence syndrome.

Pritham UA.

J Obstet Gynecol Neonatal Nurs. 2013 Sep-Oct;42(5):517-26. doi: 10.1111/1552-6909.12242. Epub 2013 Sep 4. Review.

PMID:
24020477
[PubMed - indexed for MEDLINE]
11.

Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.

O'Connor AB, Collett A, Alto WA, O'Brien LM.

J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009.

PMID:
23931660
[PubMed - indexed for MEDLINE]
12.

Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.

Metz V, Jagsch R, Ebner N, Würzl J, Pribasnig A, Aschauer C, Fischer G.

Hum Psychopharmacol. 2011 Aug;26(6):412-21. doi: 10.1002/hup.1224. Epub 2011 Aug 8.

PMID:
21823171
[PubMed - indexed for MEDLINE]
13.

Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.

Welle-Strand GK, Skurtveit S, Jones HE, Waal H, Bakstad B, Bjarkø L, Ravndal E.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):200-6. doi: 10.1016/j.drugalcdep.2012.07.001. Epub 2012 Jul 25.

PMID:
22841456
[PubMed - indexed for MEDLINE]
14.

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L.

Drug Alcohol Depend. 2005 Jul;79(1):1-10.

PMID:
15943939
[PubMed - indexed for MEDLINE]
15.

Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.

Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:53-62. doi: 10.1111/j.1360-0443.2012.04039.x.

PMID:
23106927
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, Martin PR, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:45-52. doi: 10.1111/j.1360-0443.2012.04038.x.

PMID:
23106926
[PubMed - indexed for MEDLINE]
17.

Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.

Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA.

Addiction. 2010 Dec;105(12):2151-9. doi: 10.1111/j.1360-0443.2010.03097.x. Epub 2010 Sep 20.

PMID:
20854338
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.

O'Connor A, Alto W, Musgrave K, Gibbons D, Llanto L, Holden S, Karnes J.

J Am Board Fam Med. 2011 Mar-Apr;24(2):194-201. doi: 10.3122/jabfm.2011.02.100155.

PMID:
21383220
[PubMed - indexed for MEDLINE]
Free Article
19.

Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.

Bandstra ES.

Addiction. 2012 Nov;107 Suppl 1:1-4. doi: 10.1111/j.1360-0443.2012.04059.x. No abstract available.

PMID:
23106922
[PubMed - indexed for MEDLINE]
20.

Fetal assessment before and after dosing with buprenorphine or methadone.

Salisbury AL, Coyle MG, O'Grady KE, Heil SH, Martin PR, Stine SM, Kaltenbach K, Weninger M, Jones HE.

Addiction. 2012 Nov;107 Suppl 1:36-44. doi: 10.1111/j.1360-0443.2012.04037.x.

PMID:
23106925
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk